A comparison of the Netherlands, Norway and UK familial hypercholesterolemia screening programmes with implications for target setting and the UK's NHS long term plan.

Page, Christopher; Zheng, Huiru; Wang, Haiying; Rai, Taranjit Singh; O'Kane, Maurice; Hart, Pádraig; McKee, Shane; Watterson, Steven

Page, Christopher; Zheng, Huiru; Wang, Haiying; Rai, Taranjit Singh; O'Kane, Maurice; Hart, Pádraig; McKee, Shane; Watterson, Steven.

Afiliação

Page C; Personalised Medicine Centre, School of Biomedical Science, Ulster University, C-TRIC Building, Altnagelvin Area Hospital, Derry, Northern Ireland, United Kingdom.
Zheng H; School of Computing, Ulster University, Belfast, Northern Ireland, United Kingdom.
Wang H; School of Computing, Ulster University, Belfast, Northern Ireland, United Kingdom.
Rai TS; Personalised Medicine Centre, School of Medicine, Ulster University, Derry, Northern Ireland, United Kingdom.
O'Kane M; Western Health and Social Care Trust, Altnagelvin Area Hospital, Derry, Northern Ireland, United Kingdom.
Hart P; Northern Ireland Regional Genetics Service, Belfast City Hospital, Belfast, Northern Ireland, United Kingdom.
McKee S; Northern Ireland Regional Genetics Service, Belfast City Hospital, Belfast, Northern Ireland, United Kingdom.
Watterson S; Personalised Medicine Centre, School of Medicine, Ulster University, Derry, Northern Ireland, United Kingdom.

PLOS Glob Public Health ; 3(4): e0001795, 2023.

Article em En | MEDLINE | ID: mdl-37097994

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Revista: PLOS Glob Public Health Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google